Valuation dashboard for Cardio Diagnostics Holdings, Inc. (CDIO) with P/E N/A, P/B 0.80, EV/EBITDA -0.05 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Analysis Summary
Trailing-twelve-month margins: gross margin -5.6%, operating margin -446.9%, net margin -447.7%.
At the current price of $2.00, CDIO has negative trailing earnings (P/E not meaningful) and an ROE of -93.19%. Market capitalisation stands at $6M.
Balance sheet quality for CDIO: current ratio of 9.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.80 |
| EV / EBITDA | -0.05 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CDIO | Cardio Diagnostics Holdings, Inc. | $6M | 0.80 | -93.2% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $2.00 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -93.19% |
| Return on Invested Capital | -84.55% |
| Return on Assets | -83.67% |
| Gross Margin | -555.03% |
| Operating Margin | -44690.68% |
| Net Margin | -44771.83% |
Related companies: ADIL · ADXN · BCDA · BCLI · CELZ · IBO · MTNB
Explore sector: Healthcare · Biotechnology
More sections of CDIO: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks